Left Subclavian Artery Revascularization With In Situ Laser Fenestration During Thoracic Endovascular Aortic Repair for Acute Complicated or High‐Risk Type B Aortic Dissection: Results of the LLTEVAR Trial
Journal of the American Heart Association · 16.12.2025 · 14 (24)
DOI: 10.1161/jaha.125.041720 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 16.12.2025. Verfasst von Zhiyou Peng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Shanghai Ninth People's Hospital Shanghai Jiaotong University School of Medicine 639 Zhizaoju Road Shanghai 200011 Ch…. Hauptthemen laut MEDLINE: Aorta, Thoracic, Aortic Aneurysm, Thoracic, Aortic Dissection, Blood Vessel Prosthesis Implantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Coverage of the left subclavian artery (LSA) during thoracic endovascular aortic repair (TEVAR) for type B aortic dissection (TBAD) increases the risk of major adverse events (MAEs). In situ laser‐assisted fenestration allows for LSA revascularization in both elective and urgent settings, yet its safety and efficacy lack robust multicenter data.
Methods
LLTEVAR (LSA Revascularization With Laser‐Assisted Fenestration During TEVAR) was a prospective, single‐arm, multicenter study that enrolled patients with acute complicated or high‐risk acute TBAD. The primary safety end point was freedom from composite MAEs (mortality, stroke, myocardial infarction, paraplegia, type Ia endoleak, and retrograde aortic dissection/intramural hematoma) within 30 days after the procedure. Univariate and multivariable analyses identified risk factors for composite MAEs.
Results
A total of 100 patients (mean age, 60.5±12.6 years) were enrolled at 5 vascular centers between July 2018 and September 2021. The technical success rate of LSA fenestration was 98.0% (98/100). The 30‐day primary safety end point was 86.0%. Complicated TBAD (OR, 4.04; 95% CI, 1.05–15.59; P =0.04) and type II/III aortic arch (OR, 4.61; 95% CI, 1.18–17.95; P =0.03) were significantly associated with a higher risk of composite MAEs within 30 days.
Conclusion
In situ laser‐assisted fenestration for LSA revascularization during TEVAR demonstrates favorable procedural success and acceptable short‐term outcomes in patients with acute TBAD. However, periprocedural MAEs remain a critical consideration, particularly in those with complicated TBAD with type II/III aortic arch anatomy. Further studies with comparative groups and long‐term follow‐up are warranted to validate these outcomes. Registration URL: https://clinicaltrials.gov ; Unique Identifier: NCT03845829.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, Shanghai Ninth People's Hospital Shanghai Jiaotong University School of Medicine 639 Zhizaoju Road Shanghai 200011 China.
- Vascular Center of Shanghai Jiaotong University School of Medicine 639 Zhizaoju Road Shanghai 200011 China.
- Department of Vascular Surgery Taizhou Municipal Hospital 581 Shifudadao East Road Taizhou Zhejiang 318000 China.
- Department of Vascular Surgery Shanghai Fengcheng Hospital 9983 Chuannanfeng Road Shanghai 201411 China.
- Department of Vascular Surgery (North Branch), Shanghai Ninth People's Hospital Shanghai Jiaotong University School of Medicine 280 Mohe Road Shanghai 201999 China.
ORCID-Profile: Minyi Yin, Xiaobing Liu, Xinwu Lu, Kaichuang Ye
Zitieren
APA
Peng, Z., Liang, S., Zhang, R., Qiu, P., Yin, M., Liu, G., Liu, X., Lu, X., & Ye, K. (2025). Left Subclavian Artery Revascularization With In Situ Laser Fenestration During Thoracic Endovascular Aortic Repair for Acute Complicated or High‐Risk Type B Aortic Dissection: Results of the LLTEVAR Trial. Journal of the American Heart Association, 14(24). https://doi.org/10.1161/jaha.125.041720
Vancouver
Peng Z, Liang S, Zhang R, Qiu P, Yin M, Liu G, et al. Left Subclavian Artery Revascularization With In Situ Laser Fenestration During Thoracic Endovascular Aortic Repair for Acute Complicated or High‐Risk Type B Aortic Dissection: Results of the LLTEVAR Trial. Journal of the American Heart Association. 2025;14(24). doi:10.1161/jaha.125.041720
BibTeX
@article{Peng2025,
author = {Peng, Zhiyou and Liang, Siyuan and Zhang, Rong and Qiu, Peng and Yin, Minyi and Liu, Guang and Liu, Xiaobing and Lu, Xinwu and Ye, Kaichuang},
title = {Left Subclavian Artery Revascularization With In Situ Laser Fenestration During Thoracic Endovascular Aortic Repair for Acute Complicated or High‐Risk Type B Aortic Dissection: Results of the LLTEVAR Trial},
journal = {Journal of the American Heart Association},
year = {2025},
volume = {14},
number = {24},
doi = {10.1161/jaha.125.041720}
}
EUVIMED